Efficacy and Safety of Lercanidipine and Enalapril in Patients With Essential Hypertension
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of various dosage
combinations of lercanidipine (10 and 20 mg)and enalapril (10 and 20 mg) in comparison with
their respective components and with placebo.
Phase:
Phase 2
Details
Lead Sponsor:
RECORDATI GROUP Recordati Industria Chimica e Farmaceutica S.p.A.